In Silico Methods
To help link the laboratory with the patient even more accurately, results from these biopharmaceutics tools need to be coupled with emerging in silico methods such as physiologically based pharmacokinetic (PBPK) models.
This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No 674909.
|
© accelopment Schweiz AG 2019. ALL RIGHTS RESERVED.
|